154 related articles for article (PubMed ID: 9891555)
1. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice.
Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E
Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555
[TBL] [Abstract][Full Text] [Related]
2. Selective reporting biases in cancer prognostic factor studies.
Kyzas PA; Loizou KT; Ioannidis JP
J Natl Cancer Inst; 2005 Jul; 97(14):1043-55. PubMed ID: 16030302
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck.
Argiris A; Li Y; Forastiere A
Cancer; 2004 Nov; 101(10):2222-9. PubMed ID: 15452834
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
5. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
[TBL] [Abstract][Full Text] [Related]
7. [Molecular markers of head and neck cancer].
Temam S; Janot F
Rev Prat; 2006 Oct; 56(15):1658-61. PubMed ID: 17137250
[TBL] [Abstract][Full Text] [Related]
8. Differential prognostic impact of comorbidity in head and neck cancer.
Alho OP; Hannula K; Luokkala A; Teppo H; Koivunen P; Kantola S
Head Neck; 2007 Oct; 29(10):913-8. PubMed ID: 17510970
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for the malignant triton tumor of the head and neck.
Terzic A; Bode B; Gratz KW; Stoeckli SJ
Head Neck; 2009 May; 31(5):679-88. PubMed ID: 19283843
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia in head and neck cancer: how much, how important?
Janssen HL; Haustermans KM; Balm AJ; Begg AC
Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198
[TBL] [Abstract][Full Text] [Related]
11. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
[TBL] [Abstract][Full Text] [Related]
13. [Good clinical practice in nutritional management of head and neck cancer patients].
Meuric J; Garabige V; Blanc-Vincent MP; Lallemand Y; Bachmann P
Bull Cancer; 1999 Oct; 86(10):843-54. PubMed ID: 10572235
[TBL] [Abstract][Full Text] [Related]
14. Should there be more molecular staging of head and neck cancer to improve the choice of treatments and thereby improve survival?
Almadori G; Bussu F; Paludetti G
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):117-26. PubMed ID: 18327030
[TBL] [Abstract][Full Text] [Related]
15. Personalizing cancer care: updates on head and neck cancer.
de Souza JA; Cohen EE
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
[TBL] [Abstract][Full Text] [Related]
16. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
17. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
Hoebers FJ; Pameijer FA; de Bois J; Heemsbergen W; Balm AJ; Schornagel JH; Rasch CR
Head Neck; 2008 Sep; 30(9):1216-23. PubMed ID: 18642295
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.
Dietl B; Marienhagen J; Schäfer C; Kölbl O
Clin Oncol (R Coll Radiol); 2007 May; 19(4):228-33. PubMed ID: 17433968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
